日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Design and Rationale of the Phase 2 Baricitinib Study in Apolipoprotein L1-Mediated Kidney Disease (JUSTICE)

巴瑞替尼治疗载脂蛋白 L1 介导的肾脏疾病的 II 期研究(JUSTICE)的设计和原理

Olabisi, Opeyemi A; Barrett, Nadine J; Lucas, Anika; Smith, Maurice; Bethea, Kenisha; Soldano, Karen; Croall, Stephanie; Sadeghpour, Azita; Chakraborty, Hrishikesh; Wolf, Myles

Variations in Risk of End-Stage Renal Disease and Risk of Mortality in an International Study of Patients With Type 1 Diabetes and Advanced Nephropathy

一项针对1型糖尿病合并晚期肾病患者的国际研究显示,终末期肾病风险和死亡风险存在差异。

Skupien, Jan; Smiles, Adam M; Valo, Erkka; Ahluwalia, Tarunveer S; Gyorgy, Beata; Sandholm, Niina; Croall, Stephanie; Lajer, Maria; McDonnell, Kevin; Forsblom, Carol; Harjutsalo, Valma; Marre, Michel; Galecki, Andrzej T; Tregouet, David-Alexandre; Wu, Chun Yi; Mychaleckyj, Josyf C; Nickerson, Helen; Pragnell, Marlon; Rich, Stephen S; Pezzolesi, Marcus G; Hadjadj, Samy; Rossing, Peter; Groop, Per-Henrik; Krolewski, Andrzej S

Increased plasma kidney injury molecule-1 suggests early progressive renal decline in non-proteinuric patients with type 1 diabetes.

血浆肾损伤分子-1 水平升高提示 1 型糖尿病非蛋白尿患者早期出现进行性肾功能下降

Nowak Natalia, Skupien Jan, Niewczas Monika A, Yamanouchi Masayuki, Major Melissa, Croall Stephanie, Smiles Adam, Warram James H, Bonventre Joseph V, Krolewski Andrzej S